https://padlet.com/helsinnholding/About Established in 1976 by Dr. Gabriela Braglia, Helsinn Holding, SA, is a family owned, Lugano, Switzerland-based pharmaceutical and biotech company dedicated to improving cancer care and patient outcomes through ongoing research, development, and drug manufacturing processes. To this end, the firm implements a 360 degree approach to quality assurance, a dedication that has allowed Helsinn to establish itself not only as a leader in areas of cancer care, but with a number of additional rare cancers and diseases. Over the years, the company has successfully expanded into the research and development of medications and therapies for conditions such as Prader-Willi syndrome and others. Led by vice chairman and chief executive officer Riccardo Braglia, Helsinn has secured a number of patents for pharmaceutical drugs since its founding. Over that period of time, the organization has also achieved industry honors and accolades, such as Global CEO Cancer Gold Standard Accreditation in 2018. The Helsinn Holding leadership team also manages subsidiaries such as Helsinn Advanced Synthesis, a leading contract manufacturing organization (CMDO)in oncology synthesis. en-us 2021-05-29 04:42:38 UTC 2026-03-01 07:23:34 UTC hello@padlet.com helsinnholding https://padlet.com/helsinnholding/About/wish/1798453262 “Cancer cachexia is a multifactorial wasting syndrome estimated to affect half of cancer patients, in particular those affected by advanced lung or gastro-intestinal cancer, and can lead to death in 22 percent of individuals with cancer. Involuntary weight loss and anorexia are main characteristics of cancer cachexia, they can already be present at time of cancer diagnosis, and can lead to progressive deterioration of a patient performance status and quality of life.]]> 2021-10-07 02:47:17 UTC https://padlet.com/helsinnholding/About/wish/1798453262 helsinnholding https://padlet.com/helsinnholding/About/wish/1820662063 Located in Lugano, Switzerland, Helsinn Holding, SA was established as a pharmaceutical and biotech company in 1976. The company operates to improve the quality of cancer care and medical products for rare diseases. In 2021, Helsinn Holding made a poster presentation at the Academy of Managed Care Pharmacy (AMCP) National Meeting.]]> 2021-10-16 02:39:34 UTC https://padlet.com/helsinnholding/About/wish/1820662063 helsinnholding https://padlet.com/helsinnholding/About/wish/1847140122 Helsinn Holding, SA is a pharmaceutical and biotech company based in Lugano, Switzerland. A family-owned organization established by Dr. Gabriele Braglia 45 years ago and now managed by his son and CEO Riccardo Braglia, Helsinn Holding focuses primarily on the research, development, manufacturing, and sales of oncology and pharmaceutical products used for treating cancer and rare diseases.

]]> 2021-10-27 04:21:47 UTC https://padlet.com/helsinnholding/About/wish/1847140122